Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer
Publication in refereed journal


Times Cited
Web of Science1WOS source URL (as at 02/06/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractRecent data have shown anterior gradient 2 (AGR2) to be a novel oncogene overexpressed in luminal breast cancers. However, many studies only focused on its relationship with treatment resistance, and the clinical relevance of AGR2 has not been widely evaluated.
All Author(s) ListLacambra MD, Tsang JYS, Ni YB, Chan SK, Tan PH, Tse GM
Journal nameAnnals of Surgical Oncology
Year2015
Month10
Day1
Volume Number22
Issue Number11
PublisherSPRINGER
Pages3489 - 3496
ISSN1068-9265
eISSN1534-4681
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; Surgery

Last updated on 2020-03-06 at 01:13